Development
Dolby Laboratories, Inc.
DLB
$72.56
$0.580.81%
NYSE
| 12/29/2023 | 09/29/2023 | ||||
|---|---|---|---|---|---|
| Revenue | 8.61% | -2.62% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 8.61% | -2.62% | |||
| Cost of Revenue | -9.82% | -14.36% | |||
| Gross Profit | 11.18% | -0.72% | |||
| SG&A Expenses | -10.61% | 4.22% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -8.98% | 0.87% | |||
| Operating Income | 210.33% | -30.26% | |||
| Income Before Tax | 794.86% | -61.98% | |||
| Income Tax Expenses | 1,614.51% | -111.90% | |||
| Earnings from Continuing Operations | 582.09% | -39.60% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | 16.90% | -11,933.33% | |||
| Net Income | 629.16% | -43.98% | |||
| EBIT | 210.33% | -30.26% | |||
| EBITDA | 102.97% | -18.40% | |||
| EPS Basic | 631.56% | -43.99% | |||
| Normalized Basic EPS | 151.97% | -17.20% | |||
| EPS Diluted | 641.94% | -45.29% | |||
| Normalized Diluted EPS | 151.71% | -17.33% | |||
| Average Basic Shares Outstanding | -0.34% | 0.04% | |||
| Average Diluted Shares Outstanding | -0.24% | 0.22% | |||
| Dividend Per Share | 0.00% | 11.11% | |||
| Payout Ratio | -0.85% | 0.78% | |||